IQVIA Holdings Inc. (NYSE:IQV) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of IQVIA Holdings Inc. (NYSE:IQV) have been assigned an average recommendation of “Moderate Buy” from the nineteen research firms that are presently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $257.87.

IQV has been the topic of several research reports. Royal Bank of Canada restated an “outperform” rating and issued a $270.00 target price on shares of IQVIA in a research note on Wednesday. Deutsche Bank Aktiengesellschaft decreased their target price on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Redburn Atlantic initiated coverage on shares of IQVIA in a research note on Monday, October 14th. They set a “buy” rating and a $276.00 price objective for the company. Truist Financial lowered their target price on IQVIA from $286.00 to $265.00 and set a “buy” rating on the stock in a research report on Monday, November 4th. Finally, BTIG Research decreased their price target on IQVIA from $290.00 to $260.00 and set a “buy” rating for the company in a research note on Friday, November 1st.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of IQV. Capital Performance Advisors LLP acquired a new position in IQVIA in the 3rd quarter worth about $27,000. Park Place Capital Corp acquired a new stake in IQVIA during the third quarter worth $28,000. Opal Wealth Advisors LLC purchased a new stake in IQVIA in the 2nd quarter valued at about $27,000. Itau Unibanco Holding S.A. acquired a new position in shares of IQVIA in the 2nd quarter worth approximately $29,000. Finally, International Assets Investment Management LLC acquired a new stake in shares of IQVIA in the second quarter valued at $32,000. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Stock Performance

Shares of IQVIA stock opened at $201.05 on Friday. IQVIA has a 52 week low of $187.62 and a 52 week high of $261.73. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The stock has a market capitalization of $36.49 billion, a price-to-earnings ratio of 26.39, a PEG ratio of 2.08 and a beta of 1.49. The firm has a fifty day moving average of $214.01 and a two-hundred day moving average of $224.77.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.